Organigram Global Inc. (OGI) stock
Close on Nov 11, 2026Market cap $114.79MP/E –Yield –
Organigram Global Inc. grew revenue 77.8% to C$259.18M over fiscal 2025. Free cash flow was -C$24.61M. At the latest close the market valued the company at C$161.92M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Sep 30, 2025
Valuation
- Market cap
- C$161.92M
- P/E ratio
- –
- Price to sales
- 0.62
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -15.20%
Fundamentals
- Revenue
- C$259.18M
- EPS, diluted
- -0.19 CAD
- Free cash flow
- -C$24.61M
Trading
- Previous close
- $0.85
- Open
- $0.85
- Day's range
- $0.84 – $0.88
- Volume
- 580,939
- Average volume (20 days)
- 575,068
- Beta (5 years)
- 1.52
- RSI (14 days)
- 34.1
- Volatility (1 year)
- 56.9%
- Relative volume
- 0.75×
- WACC
- 12.5%
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | OGI | S&P 500 | Difference | OGI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -11.0% | -2.4% | −8.6 pts | ||
| 3 months | -30.6% | -1.2% | −29.4 pts | ||
| Year to date | -49.2% | +12.3% | −61.5 pts | ||
| 1 year | -47.9% | +12.4% | −60.4 pts | ||
| 3 years | -30.6% | +78.8% | −109.4 pts | -11.5% | +21.4% |
| 5 years | -90.3% | +75.2% | −165.5 pts | -37.3% | +11.9% |
| 10 years | -90.8% | +311.1% | −401.9 pts | -21.2% | +15.2% |
Six years at a glance
Fiscal years 2018 to 2025, CAD
Revenue
Gross profit
Operating income
EPS, diluted
Free cash flow
Press releases
Releases Organigram Global filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Organigram Global
Pharmaceutical Preparations
The company operates in the cannabis industry, focusing on the production, processing, and commercialization of cannabis and derivative products. Its product portfolio includes dried cannabis flower, trim, concentrated extracts, formulated extracts, and vape cartridges. In addition to finished goods, the business engages in brand licensing, commercial agreements, and extraction partnerships across the cannabis value chain. These products and services are supplied to commercial buyers, wholesale partners, and adult-use or medical consumers in regulated cannabis markets.
Company profile, executives and historyOrganigram Global stock: common questions
What is Organigram Global's stock price?
OGI closed at $0.85 on Nov 11, 2026, up 0.15% on the day.
What is Organigram Global's market cap?
Organigram Global was worth $114.79M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is OGI's P/E ratio?
Organigram Global lost money over fiscal 2025 (diluted EPS -0.19 CAD), so it has no meaningful P/E ratio.
How much revenue does Organigram Global make?
Organigram Global reported revenue of C$259.18M for fiscal 2025, up 77.8% from a year earlier.
Does Organigram Global pay a dividend?
No. Organigram Global has not paid a cash dividend over the last twelve months.
How has OGI stock performed over the past year?
Including dividends, OGI returned -47.9% over the past year, against +12.4% for the S&P 500.
Who are Organigram Global's competitors?
Companies most similar to Organigram Global by business, industry and size include INCR, CGC, ACB, VREOF, LGND.
See a number that looks wrong?